Clinical Trial Update: Enavogliflozin for the Management of Patients With Amyloid CardiomyopaThy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating enavogliflozin for amyloid cardiomyopathy; status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyloid Cardiomyopathy

Drugs mentioned

• Enavogliflozin (enavogliflozin)

Snippet

Sponsor: Seoul St. Mary's Hospital | Conditions: Amyloid Cardiomyopathy | Phase 4 | Status: NOT_YET_RECRUITING